MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/25785826.2025.2515688

Медицинская библиотека · Immunological medicine · 2025

Immune checkpoint inhibitor-induced myocarditis and multiple adverse events with pre-existing rheumatoid arthritis: a case report and literature review.

Kachi Shion, Shirakashi Mirei, Nomizo Takashi, Onishi Mei, Toda Kato Eri, Nobashi Tomomi W, Onizawa Hideo, Hiwa Ryosuke, Tsuji Hideaki, Akizuki Shuji, Nakashima Ran, Onishi Akira, Yoshifuji Hajime, Tanaka Masao, Murakami Kosaku, Morinobu Akio

СтатьяКлинический случайОбзорПеревод в очереди

Аннотация

Immune checkpoint inhibitors (ICIs) can trigger immune-related adverse events (irAEs) and rheumatoid arthritis (RA) reactivation in cancer patients with pre-existing RA. Studies indicate RA reactivation occurs in approximately 50% of these patients, while new irAEs develop in 25-50% of ICI-treated patients. Furthermore, ICI-induced myocarditis has been reported to have a high mortality rate, ranging from 25% to 50%. No prior reports have detailed the clinical course of ICI-induced myocarditis in patients with RA. We describe a 77-year-old man with RA who developed myocarditis, myositis, and RA flare following treatment with the PD-LI inhibitor, atezolizumab, for small-cell lung cancer. High-dose glucocorticoid (GC) therapy and intravenous immunoglobulin improved myocarditis and myositis. Corticosteroid tapering led to organizing pneumonia, necessitating a dosage adjustment. Once resolved, tapering resumed. During irAEs treatment, the patient maintained a partial response without cancer recurrence for ten months, and required no further cancer-specific therapy. To our knowledge, this is the first detailed report of ICI-induced myocarditis in a patient with pre-existing RA. Our findings emphasize the importance of vigilant monitoring of both irAEs and RA disease activity for optimal patient management.

Для цитирования: Kachi Shion, Shirakashi Mirei, Nomizo Takashi, Onishi Mei, Toda Kato Eri, Nobashi Tomomi W, Onizawa Hideo, Hiwa Ryosuke, Tsuji Hideaki, Akizuki Shuji, Nakashima Ran, Onishi Akira, Yoshifuji Hajime, Tanaka Masao, Murakami Kosaku, Morinobu Akio. Immune checkpoint inhibitor-induced myocarditis and multiple adverse events with pre-existing rheumatoid arthritis: a case report and literature review.. Immunological medicine. 2025. DOI: 10.1080/25785826.2025.2515688.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.